Posted by Michael Wonder on 10 Dec 2024
ICER releases draft evidence report on treatment for acute pain
9 December 2024 - Public comment period now open until 13 January 2025; requests to make oral comment during public meeting also being accepted.
The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of suzetrigine (Vertex Pharmaceuticals) for the treatment of acute pain.
